US Stock MarketDetailed Quotes

CMPX Compass Therapeutics

Watchlist

1.900
0.0000.00%

Close Oct 1 16:00 ET

261.42MMarket Cap-5428P/E (TTM)

Compass Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

850K

Operating revenue

--850K

--0

Cost of revenue

Gross profit

Operating expense

19.18%15.9M

31.50%12.77M

20.91%50.36M

19.44%15.39M

-5.33%11.93M

48.40%13.34M

35.21%9.71M

33.24%41.66M

-0.87%12.89M

115.20%12.6M

Selling and administrative expenses

51.61%4.72M

5.69%3.25M

5.02%12.24M

0.24%2.97M

10.26%3.1M

-0.35%3.11M

11.06%3.07M

6.69%11.66M

-13.63%2.96M

3.96%2.81M

-General and administrative expense

51.61%4.72M

5.69%3.25M

5.02%12.24M

0.24%2.97M

10.26%3.1M

-0.35%3.11M

11.06%3.07M

6.69%11.66M

-13.63%2.96M

3.96%2.81M

Research and development costs

9.30%11.17M

43.45%9.52M

27.08%38.12M

25.16%12.43M

-9.80%8.83M

74.39%10.22M

50.35%6.64M

47.50%30M

3.70%9.93M

210.43%9.79M

Operating profit

-12.81%-15.05M

-31.50%-12.77M

-20.91%-50.36M

-19.44%-15.39M

5.33%-11.93M

-48.40%-13.34M

-35.21%-9.71M

-33.24%-41.66M

0.87%-12.89M

-115.20%-12.6M

Net non-operating interest income expense

-4.37%1.97M

233.43%7.87M

52.86%1.98M

214.93%1.96M

385.61%2.06M

792.08%2.36M

3,797.14%1.29M

909.09%623K

Non-operating interest income

-4.37%1.97M

----

233.43%7.87M

52.86%1.98M

214.93%1.96M

385.61%2.06M

----

8,037.93%2.36M

32,250.00%1.29M

62,200.00%623K

Other net income (expense)

5.82%1.98M

9,270.00%1.87M

100.14%70K

Special income (charges)

--0

----

--0

----

100.14%70K

--0

-Gain on sale of property,plant,equipment

--0

----

--0

----

66.67%70K

--0

Other non- operating income (expenses)

----

5.82%1.98M

----

9,270.00%1.87M

----

Income before tax

-15.94%-13.08M

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.77%-11.59M

-100.42%-11.98M

Income tax

Net income

-15.94%-13.08M

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.68%-11.59M

-100.42%-11.98M

Net income continuous Operations

-15.94%-13.08M

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.68%-11.59M

-100.42%-11.98M

Minority interest income

Net income attributable to the parent company

-15.94%-13.08M

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.68%-11.59M

-100.42%-11.98M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-15.94%-13.08M

-37.64%-10.79M

-8.33%-42.49M

-15.71%-13.42M

16.79%-9.96M

-32.78%-11.28M

-9.42%-7.84M

52.27%-39.23M

10.68%-11.59M

-100.42%-11.98M

Basic earnings per share

-11.11%-0.1

-33.33%-0.08

10.81%-0.33

0.00%-0.1

33.33%-0.08

-12.50%-0.09

14.29%-0.06

71.76%-0.37

-100.00%-0.1

-20.00%-0.12

Diluted earnings per share

-11.11%-0.1

-33.33%-0.08

10.81%-0.33

0.00%-0.1

33.33%-0.08

-12.50%-0.09

14.29%-0.06

71.76%-0.37

-100.00%-0.1

-20.00%-0.12

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	850K	0	0	0	0	0	0	0	0	0
Operating revenue	--850K	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	19.18%15.9M	31.50%12.77M	20.91%50.36M	19.44%15.39M	-5.33%11.93M	48.40%13.34M	35.21%9.71M	33.24%41.66M	-0.87%12.89M	115.20%12.6M
Selling and administrative expenses	51.61%4.72M	5.69%3.25M	5.02%12.24M	0.24%2.97M	10.26%3.1M	-0.35%3.11M	11.06%3.07M	6.69%11.66M	-13.63%2.96M	3.96%2.81M
-General and administrative expense	51.61%4.72M	5.69%3.25M	5.02%12.24M	0.24%2.97M	10.26%3.1M	-0.35%3.11M	11.06%3.07M	6.69%11.66M	-13.63%2.96M	3.96%2.81M
Research and development costs	9.30%11.17M	43.45%9.52M	27.08%38.12M	25.16%12.43M	-9.80%8.83M	74.39%10.22M	50.35%6.64M	47.50%30M	3.70%9.93M	210.43%9.79M
Operating profit	-12.81%-15.05M	-31.50%-12.77M	-20.91%-50.36M	-19.44%-15.39M	5.33%-11.93M	-48.40%-13.34M	-35.21%-9.71M	-33.24%-41.66M	0.87%-12.89M	-115.20%-12.6M
Net non-operating interest income expense	-4.37%1.97M		233.43%7.87M	52.86%1.98M	214.93%1.96M	385.61%2.06M		792.08%2.36M	3,797.14%1.29M	909.09%623K
Non-operating interest income	-4.37%1.97M	----	233.43%7.87M	52.86%1.98M	214.93%1.96M	385.61%2.06M	----	8,037.93%2.36M	32,250.00%1.29M	62,200.00%623K
Other net income (expense)		5.82%1.98M					9,270.00%1.87M	100.14%70K	0
Special income (charges)	--0	----	--0	--0	--0	--0	----	100.14%70K	--0	--0
-Gain on sale of property,plant,equipment	--0	----	--0	--0	--0	--0	----	66.67%70K	--0	--0
Other non- operating income (expenses)	----	5.82%1.98M	----	----	----	----	9,270.00%1.87M	----	----	----
Income before tax	-15.94%-13.08M	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.77%-11.59M	-100.42%-11.98M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-15.94%-13.08M	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.68%-11.59M	-100.42%-11.98M
Net income continuous Operations	-15.94%-13.08M	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.68%-11.59M	-100.42%-11.98M
Minority interest income
Net income attributable to the parent company	-15.94%-13.08M	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.68%-11.59M	-100.42%-11.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-15.94%-13.08M	-37.64%-10.79M	-8.33%-42.49M	-15.71%-13.42M	16.79%-9.96M	-32.78%-11.28M	-9.42%-7.84M	52.27%-39.23M	10.68%-11.59M	-100.42%-11.98M
Basic earnings per share	-11.11%-0.1	-33.33%-0.08	10.81%-0.33	0.00%-0.1	33.33%-0.08	-12.50%-0.09	14.29%-0.06	71.76%-0.37	-100.00%-0.1	-20.00%-0.12
Diluted earnings per share	-11.11%-0.1	-33.33%-0.08	10.81%-0.33	0.00%-0.1	33.33%-0.08	-12.50%-0.09	14.29%-0.06	71.76%-0.37	-100.00%-0.1	-20.00%-0.12
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data